Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Retacrit

Retacrit 1 000 IU/0.3 mL solution for injection in pre-filled syringe Retacrit 2 000 IU/0.6 mL solution for injection in pre-filled syringe Retacrit 3 000 IU/0.9 mL solution for injection in pre-filled syringe Retacrit 4 000 IU/0.4 mL solution for injection in pre-filled syringe Retacrit 5 000 IU/0.5 mL solution for injection in pre-filled syringe Retacrit 6 000 IU/0.6 mL solution for injection in pre-filled syringe Retacrit 8 000 IU/0.8 mL solution for injection in pre-filled syringe Retacrit 10 000 IU/1 mL solution for injection in pre-filled syringe Retacrit 20 000 IU/0.5 mL solution for injection in pre-filled syringe Retacrit 30 000 IU/0.75 mL solution for injection in pre-filled syringe Retacrit 40 000 IU/1 mL solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 16–17

HOS-119592 · Präparat HOS-094973

16  MedDRA System Organ Adverse Reaction (Preferred Frequency Classification (SOC) Term Level) 1 Common in dialysis 2 Includes arterial and venous, fatal and non fatal events, such as deep venous thrombosis, pulmonary emboli, retinal thrombosis, arterial thrombosis (including myocardial infarction), cerebrovascular accidents (including cerebral infarction and cerebral haemorrhage) transient ischaemic attacks, and shunt thrombosis (including dialysis equipment) and thrombosis within arteriovenous shunt aneurisms 3 Addressed in the subsection below and/or in section 4.4

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.